Cardiol Therapeutics, Inc. (CRDL)
1.00
-0.02
(-1.96%)
USD |
NASDAQ |
Feb 20, 16:00
1.01
+0.01
(+1.00%)
After-Hours: 20:00
Cardiol Therapeutics EPS Diluted (Quarterly) : -0.0854 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.236M |
| Total Expenses (Quarterly) | 7.236M |
| Enterprise Value | 103.42M |
| Earnings Yield | -29.98% |
| Normalized Earnings Yield | -29.98 |